Troponin T release is associated with silent myocardial ischaemia in black men: The SABPA Study

Madelein E Griffiths1, Leoné Malan1, Rhena Delport2

  • 11 Hypertension in Africa Research Team, North-West University, South Africa.

Insights

High sensitivity cardiac troponin T (hs-cTnT) may indicate silent myocardial ischemia (SMI) and predict systolic hypertension. hs-cTnT cut-points differ between black and white South Africans, suggesting ethnic-specific reference values are needed for risk stratification.

Area of Science:

  • Cardiology
  • Biomarkers
  • Ethnic Health Disparities

Background:

  • High sensitivity cardiac troponin T (hs-cTnT) is a key marker for myocardial damage.
  • hs-cTnT may reflect silent myocardial ischemia (SMI) and ventricular strain.
  • Ethnic variations in cardiovascular disease risk factors are well-documented.

Purpose of the Study:

  • To compare hs-cTnT levels between black and white South Africans.
  • To investigate the association between hs-cTnT and SMI.
  • To evaluate hs-cTnT's ability to predict systolic hypertension in a bi-ethnic cohort.

Main Methods:

  • A bi-ethnic cohort (n=404) of black and white South Africans (aged 20-65) with similar socioeconomic status.
  • 24-hour ambulatory blood pressure, electrocardiogram, and cardiometabolic variables were measured.
  • Multivariate linear regression and receiver operating characteristic (ROC) curve analyses were performed.

Main Results:

  • Black participants exhibited higher prevalence of hypertension, elevated glycated hemoglobin, and more frequent/longer SMI events.
  • hs-cTnT showed positive associations with SMI events and duration in black males.
  • A lower hs-cTnT cut-point (≥4.2 pg/ml) predicted systolic hypertension in black participants compared to white participants (≥5.6 pg/ml).

Conclusions:

  • hs-cTnT may serve as a marker for SMI and predict systolic blood pressure increases.
  • hs-cTnT could be valuable in identifying clusters of cardiovascular disease risk factors.
  • Ethnic- and sex-specific reference values for hs-cTnT are recommended for accurate cardiovascular risk stratification.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
506
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
316
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
594